CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 63 filers reported holding CIDARA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,000 | +50.0% | 6,452 | +99.0% | 0.00% | – |
| Q2 2023 | $4,000 | -85.2% | 3,242 | -85.1% | 0.00% | – |
| Q1 2023 | $27,000 | – | 21,759 | +144960.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 15 | -99.2% | 0.00% | – |
| Q2 2021 | $4,000 | -60.0% | 1,980 | -48.5% | 0.00% | – |
| Q1 2021 | $10,000 | +66.7% | 3,846 | +32.3% | 0.00% | – |
| Q4 2020 | $6,000 | – | 2,908 | +96833.3% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 3 | -99.5% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 614 | +29.5% | 0.00% | – |
| Q3 2019 | $1,000 | – | 474 | +1002.3% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 43 | -91.5% | 0.00% | – |
| Q1 2017 | $4,000 | -50.0% | 504 | -33.5% | 0.00% | – |
| Q4 2016 | $8,000 | +100.0% | 758 | +157.8% | 0.00% | – |
| Q3 2015 | $4,000 | -20.0% | 294 | -10.6% | 0.00% | – |
| Q2 2015 | $5,000 | – | 329 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,627,670 | $1,533,591 | 1.88% |
| 5AM Venture Management, LLC | 1,134,511 | $1,068,936 | 0.31% |
| Nantahala Capital Management | 2,538,406 | $2,391,686 | 0.20% |
| BVF INC/IL | 6,861,127 | $6,464,554 | 0.17% |
| Monashee Investment Management LLC | 369,099 | $347,765 | 0.14% |
| West Family Investments, Inc. | 368,910 | $347,587 | 0.12% |
| JEPPSON WEALTH MANAGEMENT, LLC | 137,560 | $129,609 | 0.06% |
| XTX Topco Ltd | 202,758 | $191,039 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 136,974 | $129 | 0.01% |
| Callan Capital, LLC | 103,462 | $97,482 | 0.01% |